Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Exact Therapeutics AS (EXTX)

Oslo
Currency in NOK
Disclaimer
5.75
0.00(0.00%)
Closed
EXTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
5.755.75
52 wk Range
4.8015.50
Prev. Close
5.75
Open
5.75
Day's Range
5.75-5.75
52 wk Range
4.8-15.5
Volume
0
Average Volume (3m)
3,281
1-Year Change
-64.06%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
EXTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Exact Therapeutics AS Company Profile

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. EXACT Therapeutics AS has a collaboration with GE Healthcare for the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy; and with Agenus Inc. to develop proprietary immune checkpoint inhibitors in combination with EXACT’s Acoustic Cluster Technology, in pancreatic cancer. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.

Compare EXTX to Peers and Sector

Metrics to compare
EXTX
Peers
Sector
Relationship
P/E Ratio
−3.4x−4.0x−0.6x
PEG Ratio
0.09−0.030.00
Price/Book
10.6x2.0x2.6x
Price / LTM Sales
-130.4x3.2x
Upside (Analyst Target)
-158.1%44.2%
Fair Value Upside
Unlock9.5%7.9%Unlock

FAQ

What Is the Exact Therapeutics AS (EXTX) Stock Price Today?

The Exact Therapeutics AS stock price today is 5.75

What Stock Exchange Does Exact Therapeutics AS Trade On?

Exact Therapeutics AS is listed and trades on the Oslo stock exchange.

What Is the Stock Symbol for Exact Therapeutics AS?

The stock symbol for Exact Therapeutics AS is "EXTX."

What Is the Exact Therapeutics AS Market Cap?

As of today, Exact Therapeutics AS market cap is 184.46M.

What is Exact Therapeutics AS Earnings Per Share?

The Exact Therapeutics AS EPS is -1.66.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.